請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/49172
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 宋麗英(Li-Ying Sung) | |
dc.contributor.author | Chia-Chia Liu | en |
dc.contributor.author | 劉佳佳 | zh_TW |
dc.date.accessioned | 2021-06-15T11:18:11Z | - |
dc.date.available | 2016-08-25 | |
dc.date.copyright | 2016-08-25 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-19 | |
dc.identifier.citation | REFERENCES
Aitken, A. (2006). 14-3-3 proteins: A historic overview. Semin Cancer Biol. 16(3):162-172. Aitken, A. (2011). Post-translational modification of 14-3-3 isoforms and regulation of cellular function. Semin Cell Dev Biol. 22(7):673-680. Akerfelt, M., Morimoto R. I., Sistonen L. (2010). Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol. 11(8):545-555. Ban, K. C., Singh H., Krishnan R., Seow H. F. (2003). GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma. Cancer Lett. 199(2):201-208. Basset, P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M., Podhajcer O. L., Chenard M. P., Rio M. C., Chambon P. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348(6303):699-704. Benzinger, A., Popowicz G. M., Joy J. K., Majumdar S., Holak T. A., Hermeking H. (2005). The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization. Cell Res. 15(4):219- 227. Berg, D., Holzmann C., Riess O. (2003). 14-3-3 proteins in the nervous system. Nat Rev Neurosci. 4(9):752-766. Bijur, G. N. and Jope R. S. (2000). Opposing Actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3β in the regulation of HSF-1 activity. J Neurochem. 75(6):2401-2408. Bisson, C., Blacher S., Polette M., Blanc J. F., Kebers F., Desreux J., Tetu B., Rosenbaum J., Foidart J. M., Birembaut P. (2003). Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells. Int J Cancer. 105(1):7-13. Box, C., Rogers S. J., Mendiola M., Eccles S. A. (2010). Tumour-microenvironmental interactions: paths to progression and targets for treatment. Semin Cancer Biol. 20(3):128-138. Buendia, M. A. (2000). Genetics of hepatocellular carcinoma. Semin Cancer Biol. 10(3):185-200. Calderwood, S. K., Khaleque M. A., Sawyer D. B., Ciocca D. R. (2006). Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 31(3):164-172. Cancer Lett. 199(2):201-208. Carloni, V., Luong T. V., Rombouts K. (2014). Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated that ever. Liver Int. 2014; 34(6):834-843. Carmichael, J., Sugars K. L., Bao Y. P., Rubinsztein D. C. (2002). Glycogen synthease kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Hutington’s disease mutation. J Biol Chem. 277(37):33791-33798. Chen, X.L., Zhou L., Yang J., Shen F. K., Zhao S. P. Wang Y. L. (2010). Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS. Mol Med Report 3(4):589-596. Choi, J. E., Hur W., Jung C. K., Piao L. S., Lyoo K., Hong S. W., Kim S. W., Yoon H. Y., Yoon S. K. (2011). Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium. Cancer Lett. 303(2):99-107. Chuma, M., Sakamoto M., Yamazaki K., Ohta T., Ohki M., Asaka M. Hirohashi S. (2003). Expression profiling in multistage hepatocarcinogenesis:identificantion of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37(1):198-207. Csazza, A., Di Conza G., Wenes M., Finisguerra V., Deschoemaeker S., Mazzone M. (2014). Tumor stroma: a complexity dicated by the hypoxic tumor microenvironment. Oncogene 33(14):1743-1754. Dai, C., Whitesell L., Rogers A. B., Lindquist S. (2007). Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130(6):1005-1018. De Verman, K., Rao L., De Bruyne E., Menu E., Van Valckenborgh E., Van Riet I., Frassanito M. A., Di Marzo L., Vacca A., Vanderkerken K. (2014). Cancer associated fibroblasts and tumor growth: focus on multiple myeloma. Cancers 6(3):1363-1381. Desbois-Mouthon, C., Blivet-Van Eggelpoel M. J., Beurel E., Boissan M., Delelo R., Cadoret A., Capeau J. (2002). Dysregulation of glyocogen synthase kinase-3β signaling in hepatocellular carcinoma cells. Hepatology 36(6):1528-1536. Di Tommaso, L., Destro A., Seok J. Y., Balladore E., Terracciano L., Sangiovanni A., Iavarone M., Colombo M., Jang J. J., Yu E. et al. (2009). The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol. 59(4):746-754. Di Tommaso, L., Franchi G., Park Y. Y., Fiamengo B., Destro A., Morenghi E., Montoris M., Torzilli G., Tommasini M., Terracciano L. et al. (2007). Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 45(3):725-734. Ding Z. B., Xiao Y. S., Yan J., Qiu S. J., Fan J., Zhou J. et al. (2013). αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology 57(6):2235-2247. Dougherty, M.K., Morrison D. K. (2004). Unlocking the code of 14-3-3. J Cell Sci. 117(10):1875-1884. El-Serag, H. B., Rudolph L. (2007). Hepatocellular carcinoma:epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557-2576. Farazi, P. A., Depinho R. A. (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 6(9):674-687. Feng, F., Chang R., Yang L. (2012). Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo. Cancer 118(7):1782-1794. Freeman, A. K., Morrison D. K. (2011). 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol. 22(7):681-687. Ghaffary, A., Li Y., Kilani R. T., Ghahary A. (2010). 14-3-3σ associates with cell surface aminopeptidase in the regulation of matrix metalloproteinase-1. J Cell Sci. 123(17):2996-3005. Ghaffary, A., Marcoux Y., Karimi-Busheri F. (2005). Differentiated keratinocyte-releasable stratifin (14-3-3σ) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol. 124(1):170-177. Ghorbani, S., Fossbakk A., Jorge-Finnigan A., Flydal M.I., Haavik J., Kleppe R. (2016). Regulation of tyrosine hydroxylase is preserved across different homo- and heterodimeric 14-3-3 proteins. Amino Acids. 48(5):1221-1229. Gorelik, E., Wiltrout R. H., Brunda M. J., Holden H. T., Herberman R. B. (1982). Augmentation of metastasis formation by thioglycollate-elicited macrophages. Int J Cancer. 29(5):575-81. Hagemann, T., Robinson S. C., Schulz M., Trumper L., Balkwill F. R., Binder C. (2004). Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25(8):1543-1549. Hagen, T., Di Daniel E., Culbert A. A., Reith A. D. (2002). Expression and characterization of GSK-3β mutants and their effect on beta-catenin phosphorylation in intact cells. J Biol Chem. 277(26):23330-23335. He, B., Meng Y. H., Mivechi N. F. (1998). Glycogen synthase kinase 3β and extracellular signal regulated kinase inactivate heat shock transcription factor 1 by facilitationg the disappearance of transcriptionally active granules after hear shock. Mol Cell Biol. 18(11):6624-6633. Heppener, K. J., Matrisian L. M., Jensen R. A., Roadgers W. H. (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 149(1):273-82. Hermeking, H. (2003). The 14-3-3 cancer connection. Nat Rev Cancer. 3(12):931-943. Hermeking, H., Benzinger A. (2006). 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol. 16(3):183-192. Horie-Inoue K. and Inoue S. (2006). Epigenetic and proteolytic inactivation of 14-3-3σ in breast and prostate cancers. Seminars in Cancer Biology 16(3):235-239. Huang, X. Y., Ke A. W., Shi G. M., Zhang X., Zhang C., Shi Y. H., Wang X. Y., Ide, M., Saito K., Tsutsumi S., Tsuboi K., Yamaguchi S., Asao T., Kuwano H., Nakajma T. (2007). Over-expression of 14-3-3σ in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C. Oncol Rep. 18(6):1451-1456. Inagawa, S, Itabashi M., Adachi S., Kawamoto T., Hori M., Shimazaki J., Yoshimi F., Fukao K. (2002). Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res. 8(2):450-456. Jia, Y. L., Shi L., Zhou J. N., Fu C. J., Chen L., Yuan H. F., Wang Y. F., Yan X. L., Xu Y. C., Zeng Q. et al. (2011). Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis. Hepatology 54(5):1808-1818. Jin, X., Moskophidis D., Mivechi N. (2011). Heat shock transcription factor 1 is a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome. Cell Metab. 14(1):91-103. Joo, M., Chi J. G., Lee H. (2005). Expressions of HSP70 and HSP27 in hepatocellular carcinoma. J Korean Med Sci. 20(5):829-834. Kjarland, E., Keen T. J., Kleppe R. (2006). Does isoform diversity explain functional differences in the 14-3-3 protein family? Curr Pharm Biotechnol. 7(3):217-223. Ko, B. S., Chang T. C., Hsu C., Chen Y. C., Shen T. T. L., Chen S. C., Wang J., Wu K. K., Jan Y. J., Liou J. Y. (2011a). Overexpression of 14-3-3ε predicts tumor metastasis and poor survival in hepatocellular carcinoma. Histopathology 58(5):701-711. Ko, B. S., Lai I. R., Chang T. C., Liu T. A., Chen S. C., Wang J., Jan Y. J., Liou J. Y. (2011b). Involvment of 14-3-3γ overexpression in extrahepatic metastasis of hepatolceular carcinoma. Hum Pathol. 42(1):129-135. Lam, E., Kilani R. T., Li Y., Tredget E. E. Ghahary A. (2005). Stratifin-induced matrix metalloproteinases-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinases activation. J Invest Dermatol. 125(2):230-238. Li, Z., Dong Z., Myer D., Yip-Schneider M., Liu J., cui P., Schmidt C.M., Zhang J.T. (2010). Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers. BMC Cancer 10:598. Li, L., Jin R., Zhang X., Lv Fu., Liu L., Liu D., Liu D., Liu K., Li N., Chen D. (2012). Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma. Hepatology 56(4):1380-1390. Li, Z., Liu J.Y., J.Y., Zang J. T. (2009). 14-3-3σ, the double-edged sword of human cancers. Am J Transl Res 1(4):326-340. Li, T., Xie J., Shen C., Cheng D., Shi Y., Wu Z., Zhan Q., Deng X., Chen H., Shen B. et al. (2014). miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14. PLoS One 9:e115577. Liao, M, Tong P., Zhao J., Zhang Y., Li Z., Wang J., Feng X., Hu M., Pan Y. (2012). Prognostic value of matrix metalloproteinases-1/proteinases-activated receptor-1 signaling axis in hepatocellular carcinoma. Pathol Oncol Res. 18:397-403. Liu, C. C., Jan Y. J., Ko B. S., Wu Y. M., Liang S. M., Chen S. C., Lee Y. M., Liu T. A., Chang T. C., Wang J. et al. (2014). 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma. BMC Cancer 14:425. Liu, T. A., Jan Y. J., Ko B. S., Chen S. C., Liang S. M., Hung Y. L., Hsu C., Shen T. L., Lee Y. M., Chen P. F. et al. (2011). Increased expression of 14-3-3beta promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. Am J Pathol. 179(6):2698-2708. Liu, T. A., Jan Y. J., Ko B. S., Wu Y. J., Lu Y. J., Liang S. M., Liu C. C., Chen S. C. et al. (2015). Regulation of aldo-keto0reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma. Oncotarget. 6(36):38967-38982. Liu, L. X., Lee N. P., Chan V. W., Xue W., Zender L., Zhang C., Mao M., Dai H., Wang X. L., Xu M. Z. et al. (2009). Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 50(5):1453-1463. Liu, J., Chen S., Wang W., Ning B. F., Chen F., Shen W., Ding J., Chen W., Xie W. F., Zhang X. (2016). Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways. Cancer Lett. 379(1):49-59. Lodygin D. and Hermeking H. (2005). The role of epigenetic inactivation of 14-3-3σ in human cancer. Cell Research 15(4):237-246. Lodygin D. and Hermeking H. (2006). Epigenetic silencing of 14-3-3sigma in cancer. Seminars in Cancer Biology 16(3):214-224. Lynch, C. C., Matrisian L.M. (2002). Matrix metalloproteinases in tumor-host cell communication. Differentiation 70(9-10):561-573. Maatta, M., Soini Y., Liakka A., Autio-Harmainen H. (2000). Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: Implications for tumor progression and clinical prognosis. Clin Cancer Res. 6(7):2726-2734. Masson, R., Lefebvre O., ONoel A, Fahime M. E., Chenard M. P., Wendling C., Kebers F., LeMeur M. Dierich A., Foidart J. M. et al. (1998). In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol. 40(6):1535-41. Mhawech, P. (2005). 14-3-3 proteins-an update. Cell Research 15(4):228-236. Morrison, D. K. (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19(1):16-23. Mueller, M. M., Fusenig N. (2004). Friends of foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 4(11):839-849. Muhlmann, G., Ofner D., Zitt M., Muller H.M., Maier H., Moser P., Schmid K.W., Zitt M., Amberger A. (2010). 14-3-3 sigma and p53 expression in gastric cancer and its clinical applications. Dis Markers. 29(1):21-29. Neupane, D. and Korc M. (2008). 14-3-3σ modulates pancreatic cancer cell survival and invasiveness. Clin Cancer Res 14(23):7614-7623. Ng, K. T., Qi X., Kong K. L., Cheung B. Y., Lo C. M., Poon R. T., Fan S. T., Man K. (2011). Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur J Cancer. 2011 Oct;47(15):2299-305. Nhieu, J. T., Renard C. A., Wei Y., Cherqui D., Zafrani E. S., Buendia M. A. (1999). Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol. 155(3):703-710. Obsil, T., Obsilova V. (2011). Structural basis of 14-3-3 protein functions. Semin Cell Dev Biol. 22(7):663-672. Obsilova, V., Kopecka M., Kosek D., Kacirova M., Kylarova S., Rezabkova L., Obsil T. (2014). Mechanisms of the 14-3-3 protein function: regulation of protein function through conformational modulation. Physiol Res. 63(1):S155-164. Peng, Q., Zhao L., Hou Y., Sun Y., Wang L., Luo H., Peng H., Liu M. (2013). Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer. PLoS One 8(4):e60321. Perathoner, A., Pirkebner D., Brandacher G., Spizzo G., Stadlmann S., Obrist P., Margreiter R., Amberger A. (2005). 14-3-3σ expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clin Cancer Res 11(9):3274-3279. Perathoner, A., Pirkebner D., Brandacher G., Spizzo G., Stadlmann S., Obrist P., Margreiter R., Amberger A. (2005). 14-3-3σ expression is an independent prognostic parameter for poor survival in colorectal cearcinoma patients. Clin Cancer Res. 11(9):3274-3279. Prange, W., Breuhahn K., Fischer F., Zilkens C., Pietsch T., Petmecky K., Eilers R., Dienes H. P., Schirmacher P. (2003). Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol. 201(2):250-259. Prasad, G. L., Valverius E. M., Mcduffie E., Copper H. L. (1992). Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ. 3(8):507-513. Qi, W., Liu X., Qiao D., Martinez J. D. (2005). Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer. 113(3):359-363. Raungrut, P., Wongkotsila A., Lirdprapamongkol K., Svasti J., Geater S. L., Phukaoloun M., Suwiwat S., Thongsukasi P. (2014). Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer. Asian Pac J Cancer Prev. 15(8):3513-2518. Sakamoto, M. (2009). Early HCC: diagnosis and molecular markers. J Gastroenterol. 44(19):108-111. Sano, T., Shimooka H., Weixa P., Segawa A., Jian Z., Motegi A., Nakayama H., Oyama T., Nakajima T. (2004). Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers. Pathol Int. 54(10):743-750. Shiba-Ishii, A. and Noguchi M. (2012). Aberrant Stratifin overexpression is regulated by tumor-associated CpG demethylation in hung adenocarcinoma. Am J Pathol 180(4):1653-1662. Shiba-Ishii, A., Kano J., Morishita Y., Sato Y., Minami Y., Noguchi M. (2011). High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma. Int J Cancer 129(10):2445-2453. Shiba-Ishii, A., Kim Y., Shiozawa T., Iyama S., Satomi K., Kano J., Sakashita S., Morishita Y., Noguchi M. (2015). Stratifin accelerates progression of lung adenocarcinoma at an early stage. Molecular Cancer 14:142. Shin, E., Ryu H. S., Kim S. H., Jung H., Jang J. J. Lee K. (2011). The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18(4):544-550. Sica, A. (2010). Role of tumor-associated macrophages in cnacer-related inflammation. Exp Oncol. 32(3):153-158. Singer, C. F., Kronsteiner N., Marton E., Kubista M., Cullen K. J., Hirtenlehner K., Seifert M., Kubista E. (2002). MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat. 72(1):69-77. Sluchanko, N. N., Gusev N. B. (2012). Oligomeric structure of 14-3-3 protein: what do we know about monomers? FEBS Lett. 586(24):4249-4256. Solinas, G., Germano G., Mantovani A., Allavena P. (2009). Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc. Biol. 86(5):1065-1073. Stambolic, V., Woodgett J. R. (1994). Mitogen inactivation of glycogen synthase kinase-3 in intact cells via serine 9 phosphorylation. Biochem J. 303(3):701-704. Suriawinata, A. and Thung S. N. (2010). Molecular signature of early hepatocellular carcinoma. Oncology. 78(suppl 1):36-39. Tremosini, S., Forner A., Boix L., Vilana R., Bianchi L., Reig M., Rimola J., Rodriguez-Lope C., Ayuso C., Sole M., Bruix J. (2012). Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut. 61(10):1481-1487. Tripathi, M., Billet S., Bhowmick N.A. (2012). Understanding the role of stromal fibroblasts in cancer progression. Cell Adh Migr. 6(3):231-235. van Heusden, G. P. (2005). 14-3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life. 57(9):623-629. Verdoodt, B., Benzinger A., Popowicz, G. M., Holark T. A., Hermeking H. (2006). Characterization of 14-3-3sigma dimerization determinants. Cell Cycle. 5(24):2920-2926. Wang, C., Zhang Y., Guo K., Wang N., Jin H., Liu Y., Qin W. (2016). Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential. Int J Cancer 138(8):1824-1834. Wang, Z., Trope C. G., Suo Z., Tr?en G., Yang G., Nesland J. M., Holm R. (2008). The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas. BMC Cancer 8:308. Whiteside, T. L. (2008). The tumor microenvironment and its role in promoting tumor growth. Oncogene. 27(45):5904-5912. Wigmore, S. J., Sangster K., McNally S. J., Harrison E. M., Ross J. A., Fearon K. C., Garden O. J. (2007). Int J Mol Med. 19(3):413-420. Wilker, E. W., Grant R. A., Artim S. C., Yaffe M. B. (2005). A structural basis for 14-3-3σ functional specificity. J Biol Chem. 280(19):18891-18898. Wong, C. M., Fan S. T., Ng I. O. (2001). beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 92(1):136-145. Wu, S. D., Ma YS, Fang Y., Liu L. L., Fu D., Shen X. Z. (2012). Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev. 38(3):218-225. Wyckoff, J., Wang W., Lin E. Y., Wang Y., Pixley F., Stanley E. R., Graf T., Pollard J. W. (2004). A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64(19):7022-7029. Xaiver, I. J., Mercier P. A., McLoughlin C. M., Ali A., Woodgett J. R., Ovsenek N. (2000). Glycogen synthase kinase-3β negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1. J Biol Chem. 275(37):29147-29152. Xu, X. J., Huang P., Yang B., Wang X., Xia J. (2014). Roles of CXCL5 on migration and invasion of liver cancer cells. J Transl Med. 12:193 Yang, X., Cao W., Zhang L., Zhang W., Zhang X., Lin H. (2012). Targeting 14-3-3zeta in cancer therapy. Cancer Gene Ther. 19(3):153-159. Zhang, Y., Li Y., Lin C., Ding J., Liao G., Tang B. (2014). Aberrant Upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma. PLoS One. 16;9(9):e107251. Zhao, J., Meyerkord C.L., Du Y., Khuri F. R., Fu H. (2011). 14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol. 22(7):705-712. Zhou, W.H., Tang F., Xu J., Wu X., Feng Z. Y., Li H. G., Lin D. J., Shao C. K., Liu Q. (2011). Aberrant upregulation of 14-3-3σ expression serves as an inferior prognostic biomarker for gastric cancer. BMC Cancer 11:397. Zou, J., Mi L., Yu X. F., Dong J. (2013). Interaction of 14-3-3σ with KCMF1 suppresses the proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol 19(24):3770-3780. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/49172 | - |
dc.description.abstract | 14-3-3σ (也稱為 stratifin, SFN) 是14-3-3家族成員之一,其調控功能在腫瘤之癌化過程目前仍然具有爭議。過去的研究結果顯示,14-3-3σ在許多惡性腫瘤發展中可能扮演著腫瘤抑制者的角色或促進腫瘤生長。此外,也有證據顯示14-3-3σ 能促進多種惡性腫瘤的發生,其中包含了肝細胞癌 (hepatocellular carcinoma, HCC)。然而,14-3-3σ 如何導致肝癌細胞的細胞增生、細胞遷移、細胞侵入及腫癌細胞轉移之分子機制目前仍未完全清楚。本論文之要著重在研究 (i) 14-3-3σ可誘導下游基因進而影響肝癌之發展; (ii) 進一步探討腫瘤微環境中 (tumor microenvironment) 14-3-3σ與腫瘤細胞及間質細胞之相互用對肝癌細胞癌進程之影響。14-3-3σ可大量表現在人體肝腫瘤組織並調控下游重要基因,熱休克因子-1 (Heat shock factor-1, HSF-1) 及熱休克蛋白70 (Heat shock protein 70, HSP70)。若以穩定表達或是短暫轉染14-3-3σ 之肝癌細胞株可增加HSF-1和HSP70表現。此外,HSF-1及HSP70亦大量表現在肝腫組織且由統計分析其三者之間有顯著之關連性。並進一步由臨床病理特性中發現,14-3-3σ及HSP70 與細胞遷移或侵入有顯著關聯性。利用穩定表達14-3-3σ肝癌細胞株證實,14-3-3σ誘導 HSF-1 及 HSP70 表現增加進而促進肝癌細胞遷移 ; 反之,若以小分子干擾核醣核酸降低細胞內HSP70表現量時,亦能有效抑制此現象。更進一步抑制β-catenin表現或活化GSK-3β訊息路徑普可顯著減少14-3-3σ促進之細胞遷移。收集穩定表現14-3-3σ 肝癌細胞株之培養液 (14-3-3σ-conditioned media, CM),將此培養液個別培養 H68 fibroblasts (纖維母細胞), THP-1 (人類單核球細胞株) and phorbol-12-myristate-13-acetate (PMA)-treated THP-1 (PMA-THP-1,PMA誘導之巨噬細胞) 三種間質細胞後,再將此間質細胞與親代肝癌細胞株 (Parental Huh-7 cell line) 同時培養在Transwell細胞培養盤上進行細胞侵入能力之分析。結果發現,14-3-3σ-CM培養之三種間質細胞皆可有增加肝癌細胞侵入能力。此外,14-3-3σ-CM培養液可以誘導多種基質轉移蛋白酶 (matrix metalloproteinases, MMPs) 大量表現。以纖維母細胞為例,14-3-3σ-CM可增加MMP-1,MMP-2, MMP-9, MMP-12,MMP-14大量表現; 在人類單核球細胞株可增加MMP-1及MMP-12; 在巨噬細胞株可增加MMP-2, MMP-12和MMP-14 。反之,若以小分子干擾核醣核酸干擾14-3-3σ分泌到胞外亦可顯著減少經14-3-3σ-CM誘發產生之MMPs表現。不論以穩定表達14-3-3肝細胞株或人工純化14-3-3σ重組蛋白 (r14-3-3σ protein) 方式,皆可證實14-3-3σ可分泌至胞外並增加周圍間質細胞產生MMPs。進一步探討其分子機轉發現,14-3-3σ-CM或r14-3-3σ蛋白誘導產生的MMPs表現是透過影響胺肽酶N (aminopeptidase N, APN) 之表現量。使用MMP抑制劑 (GM6001)或以小分子干擾核醣核酸干擾 APN 皆可有效抑制14-3-3σ-CM誘導癌細胞侵入能力。 促進細胞侵入之能力。綜合結果,本研究證實14-3-3σ調控肝癌的進程不只透過促進肝癌細胞遷移作用,亦可增加分泌型14-3-3σ (HCC-secreted 14-3-3σ) 表現誘導周圍間質細胞產生MMPs蛋白,進而幫助癌細胞增加其侵入的能力速肝癌惡化。 | zh_TW |
dc.description.abstract | 14-3-3σ (also known as stratifin, SFN) is a member of 14-3-3 family and its role in regulating tumor progression remains controversial. Results from earlier studies suggest 14-3-3σ plays as a potential tumor suppressor or promoter in various human malignancy including hepatocellular carcinoma (HCC). However, the molecular mechanism by which 14-3-3σ confers HCC cell proliferation, migration, invasion as well as tumor metastasis remains unclear. In this study, we investigated the potential downstream targets of 14-3-3σ in modulating HCC development and the interaction with surrounding tumor associated stromal cells. We found that 14-3-3σ is abundantly expressed in HCC tumors. Both heat shock factor-1α (HSF-1) and heat shock protein 70 (HSP70) are major downstream factors of 14-3-3σ. Stable or transient over-expression of 14-3-3σ induces the expression of HSF-1 and HSP70 in HCC cells. 14-3-3σ mediated cell migration is impaired by siRNA knockdown of HSP70. 14-3-3σ-induced HSF-1α/HSP70 expression and cell migration is also abolished by knockdown of β-catenin or activation of GSK-3β. Moreover, both 14-3-3σ and HSP70 overexpression associated with micro-vascular thrombin in HCC patients. The results suggested that both 14-3-3σ/HSP70 expression are potentially involved in cell migration/invasion. In addition, HCC cells co-cultured with 14-3-3σ-conditioned media (CM) treated stromal cells (H68 fibroblasts, THP-1 and phorbol-12-myristate-13-acetate (PMA)-treated THP-1 (PMA-THP-1) significantly enhanced their invasive ability compared with control-CM treated cells. Incubation with 14-3-3σ-CM induced differential expression profiles of matrix metalloproteinases (MMPs) in fibroblasts (MMP-1, MMP-2, MMP-9, MMP-12 and MMP-14), THP-1 (MMP-1 and MMP-12) and PMA-THP-1 cells (MMP-2, MMP-12 and MMP-14). In contrast, silencing of 14-3-3σ by siRNA significantly abolished 14-3-3σ-CM induced MMPs. Treatment of all stromal cells (HS68, THP-1 and PMA-THP-1) with recombinant human 14-3-3σ (r14-3-3σ) protein exhibits a similar expression profile of MMPs induced by 14-3-3σ-CM. Knockdown of aminopeptidase N (APN) significantly abrogated 14-3-3σ-CM or r14-3-3σ induced expression of MMPs in HS68 fibroblasts. Finally, HCC-secreted 14-3-3 promotes cell invasion was significantly abolished by APN siRNA or treated with GM6001 (an inhibitor of MMPs). Taken together, our findings suggest that 14-3-3σ regulates HCC tumor progression not only by promoting cancer cell migration but also educating stromal cells in the tumor-associated microenvironment. 14-3-3σ is thus a potential biomarker and therapeutic target of HCC. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T11:18:11Z (GMT). No. of bitstreams: 1 ntu-105-D98642002-1.pdf: 2430925 bytes, checksum: 746d4ac38f72da90a9f8df7c35045094 (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | ABSTRACT .........….............................................................................................. i
中文摘要 ...............….......................................................................................... ii CONTENTS ....................................................................................................... iii LIST OF TABLES ................................................................................................. .v LIST OF FIGURES .............................................................................................. .vi ABBREVIATIONS ............................................................................................... vii CHAPTER I: General introduction and literature review ....................................…1 General Introduction ..........................................................................................2 Literature Review ..........................................................................................…..3 1-1. A historical review of 14-3-3 proteins ...................................................….3 1-2. Function of 14-3-3 proteins in cellular processes ......................................5 1-3. 14-3-3 proteins and human cancers connection ........................................7 1-4. Role of 14-3-3 proteins in hepatocellular carcinoma (HCC) ........................8 1-5. Role of 14-3-3σ in hepatocellular carcinoma (HCC) ...................................9 1-6. Diagnosis and molecular markers of heat shock protein 70 (HSP70) and heat shock factor-1 (HSF-1)................................................................................... .11 1-7. Expression of GSK-3β/β –Catenin in human cancers .............................. .13 1-8. Cancer and tumor microenvironments ......................................................14 1-9. Matrix metalloproteinase proteins (MMP): cross talk between cancers and microenvironments ........................................................................................ .15 Perspective ..................................................................................................... .17 CHAPTER II: 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma ..............................…………........................................................... .19 2-1. Background ............................................................................................ .20 2-2. Materials and Methods ........................................................................... .20 2-3. Results ................................................................................................... .25 2-4. Discussion ............................................................................................. .30 CHAPTER III: Paracrine regulation of matrix metalloproteinases (MMPs) contributes to cancer cell Invasion by hepatocellular carcinoma-secreted 14-3-3σ............... .48 3-1. Background ...…...................................................................................... .49 3-2. Materials and Methods ...............…......................................................... .49 3-3. Results ................................................................................................... .54 3-4. Discussion ............................................................................................. .58 CONCLUSIONS ................................................................................................ .74 REFERENCES ................................................................................................... .76 | |
dc.language.iso | en | |
dc.title | 探討14-3-3σ調控肝細胞癌之細胞遷移與侵入所扮演的角色 | zh_TW |
dc.title | The Roles of 14-3-3σ in Regulating Cell Migration and Invasion of Hepatocellular Carcinoma | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 劉俊揚(Jun-Yang Liou) | |
dc.contributor.oralexamcommittee | 徐松錕(Song-Kun Shyue),沈湯龍(Tang-Long Shen),郭呈欽(Cheng-Chin Kuo) | |
dc.subject.keyword | 14-3-3蛋白,β-鏈蛋白,熱休克蛋白70,熱休克因子-1,肝細胞癌,胺??,腫癌微環境之間質細胞,腫瘤微環境, | zh_TW |
dc.subject.keyword | 14-3-3σ,β-catenin,HSP70,HSF-1,Hepatocellular carcinoma,APN,tumor-associated stromal cells,microenvironment, | en |
dc.relation.page | 85 | |
dc.identifier.doi | 10.6342/NTU201602675 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-08-20 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 生物科技研究所 | zh_TW |
顯示於系所單位: | 生物科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 2.37 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。